Literature DB >> 19473179

Leptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study.

Jiankang Liu1, Kenneth R Butler, Sarah G Buxbaum, Jung Hye Sung, Brenda W Campbell, Herman A Taylor.   

Abstract

BACKGROUND: To examine the association of increased plasma leptin concentration with prevalent stroke and coronary heart disease (CHD) and to examine the genetic contributions of leptin to this association in the Jackson Heart Study cohort.
METHODS: A cohort of 5170 participants aged 21-84 years who underwent Exam I during 2000-2004 was analysed. Odds ratios (OR) of prevalent stroke and CHD were calculated using a logistic regression model adjusted for age, smoking, hypertension and waist circumference (WC). Variance component analysis was used to partition the phenotypic variance of leptin into the polygenic and environmental components.
RESULTS: The prevalence of stroke and CHD was 4.04% and 5.85% in women, and 4.88% and 8.92% in men, respectively. Body mass index (BMI) and WC were highly correlated with leptin both in men and women. In multivariate analysis stratified by sex, leptin was significantly associated with stroke (OR = 1.97, 95% CI = 1.21-3.21) in women after adjustment for age, smoking, systolic blood pressure, BMI and WC (P = 0.0079). No significant association was observed in men. Heritability of sex-, age-adjusted log-transformed leptin for this cohort was 38.0% and 37.8% after further adjustment for WC and hypertension, respectively. In addition, a sibship effect was also found to be significant and explained 12.2% of the total variance of leptin (P = 0.007).
CONCLUSION: There is a significant association of leptin with stroke in women, which is partly influenced by the genetic factor. The findings suggest that leptinemia is an independent risk factor for stroke in African American women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473179      PMCID: PMC2805061          DOI: 10.1111/j.1365-2265.2009.03627.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  30 in total

1.  Familial resemblance for plasma leptin: sample homogeneity across adiposity and ethnic groups.

Authors:  Treva Rice; Yvon C Chagnon; Ingrid B Borecki; Louis Pérusse; Greg Collier; Jacques Gagnon; Arthur S Leon; James S Skinner; Jack H Wilmore; Claude Bouchard; D C Rao
Journal:  Obes Res       Date:  2002-05

2.  Study design for genetic analysis in the Jackson Heart Study.

Authors:  James G Wilson; Charles N Rotimi; Lynette Ekunwe; Charmaine D M Royal; Mary E Crump; Sharon B Wyatt; Michael W Steffes; Adebowale Adeyemo; Jie Zhou; Herman A Taylor; Cashell Jaquish
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

3.  Body size and fat distribution as predictors of stroke among US men.

Authors:  S P Walker; E B Rimm; A Ascherio; I Kawachi; M J Stampfer; W C Willett
Journal:  Am J Epidemiol       Date:  1996-12-15       Impact factor: 4.897

4.  The paradox of high risk of stroke in populations with low risk of coronary heart disease.

Authors:  D M Reed
Journal:  Am J Epidemiol       Date:  1990-04       Impact factor: 4.897

5.  Heritability of leptin levels and the shared genetic effects on body mass index and leptin in adult Finnish twins.

Authors:  J Kaprio; J Eriksson; M Lehtovirta; M Koskenvuo; J Tuomilehto
Journal:  Int J Obes Relat Metab Disord       Date:  2001-01

6.  Leptin's sexual dimorphism results from genotype by sex interactions mediated by testosterone.

Authors:  Lisa J Martin; Michael C Mahaney; Laura Almasy; Jean W MacCluer; John Blangero; Cashell E Jaquish; Anthony G Comuzzie
Journal:  Obes Res       Date:  2002-01

Review 7.  Mechanisms of obesity-associated cardiovascular and renal disease.

Authors:  John E Hall; Errol D Crook; Daniel W Jones; Marion R Wofford; Patricia M Dubbert
Journal:  Am J Med Sci       Date:  2002-09       Impact factor: 2.378

8.  Trends in stroke and coronary heart disease in the WHO MONICA Project.

Authors:  Thomas Truelsen; Markku Mähönen; Hanna Tolonen; Kjell Asplund; Ruth Bonita; Diego Vanuzzo
Journal:  Stroke       Date:  2003-05-08       Impact factor: 7.914

9.  Leptin, but not adiponectin, predicts stroke in males.

Authors:  S Söderberg; B Stegmayr; H Stenlund; L-G Sjöström; A Agren; L Johansson; L Weinehall; T Olsson
Journal:  J Intern Med       Date:  2004-08       Impact factor: 8.989

Review 10.  Impact of the obesity epidemic on hypertension and renal disease.

Authors:  John E Hall; Daniel W Jones; Jay J Kuo; Alexandre da Silva; Lakshmi S Tallam; Jiankang Liu
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

View more
  26 in total

1.  The synovial fluid adiponectin-leptin ratio predicts pain with knee osteoarthritis.

Authors:  Rajiv Gandhi; Mark Takahashi; Holly Smith; Randy Rizek; Nizar N Mahomed
Journal:  Clin Rheumatol       Date:  2010-03-28       Impact factor: 2.980

2.  Sex differences in risk factors for coronary artery disease and stroke in men and women aged 45-65 years.

Authors:  D Hochner-Celnikier; T Chajek-Shaul; O Manor
Journal:  Heart Asia       Date:  2013-10-26

3.  Leptin, adiponectin, and heart rate variability among police officers.

Authors:  Luenda E Charles; Cecil M Burchfiel; Khachatur Sarkisian; Shengqiao Li; Diane B Miller; Ja K Gu; Desta Fekedulegn; John M Violanti; Michael E Andrew
Journal:  Am J Hum Biol       Date:  2014-10-01       Impact factor: 1.937

Review 4.  Leptin, cardiovascular diseases and type 2 diabetes mellitus.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Maciej Banach
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

5.  Leptin upregulates smooth muscle cell expression of MMP-9 to promote plaque destabilization by activating AP-1 via the leptin receptor/MAPK/ERK signaling pathways.

Authors:  Ruijie Liu; Benfa Chen; Jiemin Chen; Jun Lan
Journal:  Exp Ther Med       Date:  2018-10-12       Impact factor: 2.447

6.  Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.

Authors:  Nieves Gómez-Hurtado; Alejandro Domínguez-Rodríguez; Philippe Mateo; María Fernández-Velasco; Almudena Val-Blasco; Rafael Aizpún; Jessica Sabourin; Ana María Gómez; Jean-Pierre Benitah; Carmen Delgado
Journal:  J Physiol       Date:  2017-05-23       Impact factor: 5.182

7.  Serum Leptin Levels and the Risk of Stroke: The Framingham Study.

Authors:  Hamidreza Saber; Jayandra J Himali; Ashkan Shoamanesh; Alexa Beiser; Aleksandra Pikula; Tamara B Harris; Ronenn Roubenoff; Jose Rafael Romero; Carlos S Kase; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2015-09-03       Impact factor: 7.914

8.  Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study.

Authors:  Liang He; Irina Culminskaya; Yury Loika; Konstantin G Arbeev; Olivia Bagley; Matt Duan; Anatoliy I Yashin; Alexander M Kulminski
Journal:  Exp Gerontol       Date:  2017-09-28       Impact factor: 4.032

9.  Association of serum leptin with angiographically proven cardiovascular disease and with components of the metabolic syndrome: a cross-sectional study in East Azerbaijan.

Authors:  Nafiseh Khanbabaei; Hossein Mozafar Saadati; Shahnam Valizadeh Shahbazloo; Reyhaneh Hoseinpoor; Seyed Hossein Naderi; Roya Taghvamanesh; Sakhavat Abolhasani
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-08-13

10.  Urinary metals and adipokines in midlife women: The Study of Women's Health Across the nation (SWAN).

Authors:  Xin Wang; Carrie A Karvonen-Gutierrez; Bhramar Mukherjee; William H Herman; Sung Kyun Park
Journal:  Environ Res       Date:  2020-11-04       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.